세계의 HRM(High-Resolution Melting) 분석 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global High-Resolution Melting Analysis Market size is anticipated to grow from USD 408.43 Million in 2024 to USD 859.62 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.62% during the forecast period of 2026 to 2033.

The high-resolution melting (HRM) analysis market is poised for significant growth as the demand for precise genetic analysis and molecular diagnostics escalates. HRM is a powerful technique used to analyze DNA variations, providing rapid and accurate results that are essential for applications in research, clinical diagnostics, and personalized medicine. The increasing prevalence of genetic disorders and the need for effective screening methods are driving the adoption of HRM technology across various healthcare settings. As researchers and clinicians seek to enhance their understanding of genetic variations, HRM is emerging as a vital tool in the molecular biology toolkit.

Technological advancements are propelling the capabilities of high-resolution melting analysis, making it more accessible and efficient. Innovations in instrumentation and software are enhancing the sensitivity and specificity of HRM, allowing for the detection of even subtle genetic variations. Furthermore, the integration of HRM with next-generation sequencing technologies is expanding its applications, enabling comprehensive genomic analyses that were previously unattainable. As the field of genomics continues to evolve, the demand for reliable and high-throughput analysis methods like HRM is expected to grow, positioning it as a cornerstone of modern genetic research.

Additionally, the increasing focus on personalized medicine is likely to drive the HRM analysis market forward. As healthcare shifts towards tailored treatment approaches based on individual genetic profiles, the ability to quickly and accurately assess genetic variations becomes paramount. The growing body of research supporting the clinical utility of HRM in various applications, including cancer diagnostics and infectious disease detection, is expected to further accelerate its adoption. In conclusion, the high-resolution melting analysis market is set for remarkable growth, driven by technological innovation, the demand for precision medicine, and the expanding applications of genetic analysis in healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Reagents And Consumables
• Instruments
• Software

By Application

• SNP Genotyping
• Mutation Discovery
• Epigenetics
• Species Identification
• Others

By End-User

• Research Laboratories
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Others
• COMPANIES PROFILED
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Agilent Technologies Inc.
• Illumina Inc.
• Merck KGaA
• Promega Corporation
• bioMerieux S.A.
• Takara Bio Inc.
• Sigma-Aldrich Corporation
• Canon BioMedical Inc.
• Idaho Technology Inc.
• Premier Biosoft
• Zymo Research Corporation
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Reagents And Consumables Historic and Forecast Sales By Regions
• 5.4. Instruments Historic and Forecast Sales By Regions
• 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. SNP Genotyping Historic and Forecast Sales By Regions
• 6.4. Mutation Discovery Historic and Forecast Sales By Regions
• 6.5. Epigenetics Historic and Forecast Sales By Regions
• 6.6. Species Identification Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-User
• 7.2. Historical and Forecast Data Analysis By End-User
• 7.3. Research Laboratories Historic and Forecast Sales By Regions
• 7.4. Pharmaceutical And Biotechnology Companies Historic and Forecast Sales By Regions
• 7.5. Academic And Research Institutes Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HIGH-RESOLUTION MELTING ANALYSIS COMPANIES

• 9.1. High-Resolution Melting Analysis Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Bio-Rad Laboratories Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. F. Hoffmann-La Roche Ltd.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Qiagen N.V.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Agilent Technologies Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Illumina Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Merck KGaA
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Promega Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. BioMéRieux S.A.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Takara Bio Inc.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Sigma-Aldrich Corporation
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Canon BioMedical Inc.
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Idaho Technology Inc.
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments
• 10.16. Premier Biosoft
  • 10.16.1 Company Overview
  • 10.16.2 Company Revenue
  • 10.16.3 Products
  • 10.16.4 Recent Developments
• 10.17. Zymo Research Corporation
  • 10.17.1 Company Overview
  • 10.17.2 Company Revenue
  • 10.17.3 Products
  • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies